Skip to content
← Back to this collection

PUBLICATIONS · 17351252

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2007 May
First author
Culine S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Culine S
      type
      Author
    2. name
      Kerbrat P
      type
      Author
    3. name
      Kramar A
      type
      Author
    4. name
      Théodore C
      type
      Author
    5. name
      Chevreau C
      type
      Author
    6. name
      Geoffrois L
      type
      Author
    7. name
      Bui NB
      type
      Author
    8. name
      Pény J
      type
      Author
    9. name
      Caty A
      type
      Author
    10. name
      Delva R
      type
      Author
    11. name
      Biron P
      type
      Author
    12. name
      Fizazi K
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Culine S
      type
      Author
    2. name
      Kerbrat P
      type
      Author
    3. name
      Kramar A
      type
      Author
    4. name
      Théodore C
      type
      Author
    5. name
      Chevreau C
      type
      Author
    6. name
      Geoffrois L
      type
      Author
    7. name
      Bui NB
      type
      Author
    8. name
      Pény J
      type
      Author
    9. name
      Caty A
      type
      Author
    10. name
      Delva R
      type
      Author
    11. name
      Biron P
      type
      Author
    12. name
      Fizazi K
      type
      Author
    bibliography ids
    1. nci-bib-1dd89745a900e239f39a5398
    book metadata
    content sha256
    2020c6ae343c12356daa1d32724459f1b618722d8a6db7d9128477c81e7b5289
    document type
    citation
    dois
    1. 10.1093/annonc/mdm062
    electronic publication date
    display
    2007 Mar 9
    precision
    day
    year
    2007
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17351252
    immutable id
    pubmed:17351252@2020c6ae343c12356daa1d32724459f1b618722d8a6db7d9128477c81e7b5289
    journal
    abbreviation
    Ann Oncol
    issn electronic
    Source null
    issn print
    0923-7534
    issue
    5
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    917-24
    volume
    18
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17351252
      provenance
      batch id
      e687ecc838c318f9ec65
      provider
      NCBI PubMed ESummary
      record sha256
      972cd482f3f8ae9ff522a208110944c14979ab0862fede4af6020c64131a1ebf
      response sha256
      57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
      retrieved at
      2026-09-09T23:46:11.674833+00:00
      publication date
      display
      2007 May
      precision
      month
      year
      2007
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17351252/
      title
      Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).

      Preserved source evidence · Not medical advice